Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: Two cases

British Journal of Dermatology

Volumn 146, Issue 2, 2002, Pages 320-324

  Cogrel, O ^a   Doutre, M S ^a   Marliere V ^a   Beylot Barry, M ^a   Couzigou, P ^a   Beylot, C ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Combination treatment; Hepatitis C virus; Interferon alfa; Ribavirin; Sarcoidosis; T helper 1

Indexed keywords

CORTICOSTEROID; PREDNISOLONE; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN;

ADULT; ANTIVIRAL ACTIVITY; ARTHRALGIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG TOLERANCE; FEMALE; FEVER; GRANULOMATOSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; PRIORITY JOURNAL; REMISSION; SARCOIDOSIS; SKIN BIOPSY; SKIN DISEASE; TH1 CELL; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; DRUG ERUPTIONS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; RIBAVIRIN; SARCOIDOSIS;

EID: 0036207651     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-0963.2001.04570.x     Document Type: Article

References (27)

1. Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma
2. Sarcoidosis associated with interferon alpha therapy for chronic hepatitis C
3. Sarcoidosis induced by interferon therapy for chronic myelogenous leukaemia
4. Cutaneous sarcoidosis in patient with Philadelphia-positive chronic myelogenous leukemia treated with interferon alpha
5. Sarcoidosis in interferon alpha therapy
6. Interferon alpha therapy associated with the development of sarcoidosis
7. Improvement of sarcoidosis under therapy with interferon alpha-2b for chronic hepatitis B virus infection
8. Granulomatous dermatitis with focal sarcoidal features associated with interferon beta-1b injections
9. Sarcoidose au cours d'une leucémie myéloïde chronique traitée par interféron alpha 2b
10. Combination therapy with interferon alpha-2b plus low dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemia
11. Novel liver histological changes associated with interferon treatment for chronic NANB hepatitis
12. Nodules hypodermiques sarcoidosiques au cours d'une hépatite virale C traitée par interféron alpha-2b
13. La sarcoidose: Une nouvelle complication du traitement par interféron alpha
14. Sarcoidosis following beta-interferon therapy for multiple myeloma
15. A case of subcutaneous sarcoid nodules induced by interferon alpha
16. Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C
17. Cutaneous sarcoid foreign body granulomas developing in sites of previous skin injury after systemic interferon alpha treatment for chronic hepatitis C
18. Sarcoidosis after interferon therapy for chronic active hepatitis C
19. Sarcoidose systemique au cours du traitement par interféron alpha d'une hépatite chronique virale C
20. Sarcoidosis and interferon alpha treatment
21. Sarcoidosis with selective involvement of a second liver allograft: Report of a case and review of the literature
22. Probable sarcoidose cutanée aprés bi-thérapie associant ribavirine et interféron alpha pour une hépatite chronique virale C
23. Th1/Th2 cell distribution in pulmonary sarcoidosis
24. Etiology of sarcoidosis
25. High prevalence of cutaneous reactions to interferon alpha plus ribavirin combination therapy in patients with chronic hepatitis C virus
26. Ribavirin inhibits viral-induced macrophage production of TNF alpha, IL 1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response
27. Ribavirin polarizes human T cell responses towards a type 1 cytokine profile